Gemcitabine hydrochloride and Fever - a phase IV clinical study of FDA data

Summary:

Fever is reported as a side effect among people who take Gemcitabine hydrochloride (gemcitabine hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Abraxane, and have Pancreatic carcinoma.

The phase IV clinical study analyzes which people have Fever when taking Gemcitabine hydrochloride. It is created by eHealthMe based on reports of 14,753 people who have side effects when taking Gemcitabine hydrochloride from the FDA, and is updated regularly.

What is Gemcitabine hydrochloride?

Gemcitabine hydrochloride has active ingredients of gemcitabine hydrochloride. eHealthMe is studying from 14,775 Gemcitabine hydrochloride users. Check the latest studies of Gemcitabine hydrochloride.

What is Fever?

Fever is found to be associated with 3,494 drugs and 6,195 conditions by eHealthMe. Check the latest studies of Fever.

On Jul, 07, 2026

14,753 people reported to have side effects when taking Gemcitabine hydrochloride.
Among them, 868 people (5.88%) have Fever.

Could Gemcitabine hydrochloride cause Fever?

Among these 868 people:

How long have people been on Gemcitabine hydrochloride when they have Fever? *

Click here to view more results

What is the gender of people who have Fever when taking Gemcitabine hydrochloride? *

Click here to view

What is the age of people who have Fever when taking Gemcitabine hydrochloride? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Gemcitabine hydrochloride and have Fever?

- Check whether Fever is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gemcitabine hydrochloride:

Gemcitabine hydrochloride (14,775 reports)

Fever treatments and more:

Fever (498,666 reports)

How severe was Fever and when was it recovered:

Fever in Gemcitabine hydrochloride

Expand to all the drugs that have ingredients of gemcitabine hydrochloride:

Fever and drugs with ingredients of gemcitabine hydrochloride (3,357 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gemcitabine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fever:

Fever (3,494 drugs)

Browse all the conditions that are associated with Fever:

Fever (6,195 conditions)

Related publications that referenced our studies

Schiller D, Maieron A, Sch?fl R, Donnerer J, "Drug fever due to a single dose of pantoprazole", Pharmacology, 2015 Jan .
Schiller D, Maieron A, Sch?fl R, Donnerer J, "Drug fever due to a single dose of pantoprazole", Pharmacology, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on gemcitabine hydrochloride (the active ingredients of Gemcitabine hydrochloride) and Gemcitabine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.